Best Myeloma doctors in Israel: TOP 18 doctors

Professor Ron Ram practices at Sourasky Medical Center (Ichilov), Israel's largest university hospital.

• Colleague Professor Fredi Aviv heads the Bone Marrow Transplant Unit there
• The team specializes in hematologic cancers, including myeloma
• Uses advanced treatments like cellular immunotherapy
• The center leads in autologous stem cell transplantation research

Dr. Ron Ram has performed several hundred stem cell transplants at Sourasky Medical Center – a key procedure for treating Myeloma.

• Board-certified in Internal Medicine, Hematology, and Medical Oncology
• Published over 30 scientific articles and a textbook chapter on hematology
• Completed his Hematology and Oncology fellowship at New York Medical College
• Offers an individualized approach for each transplantation patient

Dr. El Hasid has conducted over 300 bone marrow and cord blood transplants for children. She leads the Pediatric Oncohematology and Oncology Department at Dana Dwek Children's Hospital.

• Specializes in pediatric bone marrow and umbilical blood transplantation
• Member of the American Association for Hematology
• Member of the Israeli Society for Pediatric Hematooncology
• Trained at the renowned City of Hope Hospital in Los Angeles
• Authored 50 publications and 40 conference reports

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Michael Shapira is a senior hematologist known for proving age is no barrier to successful stem cell transplants. He leads the Hematology Inpatient Unit and Day Hospital at Tel Aviv Sourasky Medical Center.

• Specializes in bone marrow transplantation for older adult patients
• Treats graft versus host disease (GVHD)
• Previously a senior physician in the Stem Cell Transplant Department at Hadassah Ein Kerem Hospital
• Member of several international medical associations
• Graduated from Hebrew University of Jerusalem medical school

Dr. Fredi Aviv has focused on Myeloma for 34 years of experience at Tel Aviv's major Sourasky Medical Center.

• Specializes as an Oncohematologist, treating blood cancers specifically
• Extensive experience navigating complex blood cancer treatment protocols
• Works within one of Israel's leading and most comprehensive medical centers

Dr. Dror Levin is a leading expert in pediatric blood disorders and bone cancer, directing the children's hematology oncology department at Sourasky Medical Center.

• Specializes in treating bone cancer (sarcoma) in children
• Member of the Israel association for pediatric hemato-oncology (ISPHO)
• Trained at Rizzoli Orthopaedic Institute in Italy – a world leader in bone oncology
• Coordinates treatment for blood coagulation disorders in children

Dr. Kirshner is actively involved in myeloma research and clinical trials, including phase III trials testing new treatment combinations.

• Fellowship-trained in hematology and medical oncology at Montefiore Medical Center
• Specializes in advanced treatment approaches for myeloma
• Long experience working at prestigious Sourasky Medical Center
• Board-certified in internal medicine and oncology

Dr. Yair is an award-winning hematologist at Sourasky Medical Center, specializing in blood cancers like myeloma.

• Multiple research grants and awards for contributions to hematology
• Member of both Israeli and American Hematology Associations
• Extensive training in hematology at Tel Aviv Medical Center

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Oncohematologist Ofer Spielberg treats blood cancers at Assuta Medical Center.

• Specializes exclusively in treating myeloma and other blood disorders
• Works within a major Israeli hospital network known for advanced oncology

Professor Ben-Yehuda is Head of Hematology at Hadassah Medical Center and a recognized Dean of its Medical School.

• Over 34 years of experience of experience treating malignant blood diseases including myeloma
• Trained at the prestigious Memorial Sloan-Kettering Cancer Center in New York
• Specializes in bone marrow transplantation and advanced gene therapy
• Leads research in molecular diagnostics for hematological diseases
• Holder of the Healing with the Heart Award for exceptional patient care